One Zyme transforms global scientific, clinical, regulatory, funding, patent, deal, and conference signals into decision-ready intelligence for life sciences teams.
I can't live without One Zyme.
One Zyme's AI gives you agents built for the enterprise and designed for biopharma professionals. Ask hard-to-answer questions and extract better insight than you'll find anywhere else.
We asked One Zyme Deep Research and every leading AI platform the same question. One Zyme surfaced an order of magnitude more, especially in hard-to-see preclinical and China-originated assets.
"Give me a comprehensive list of CAR-T clinical trials in China (China sites only), along with a comprehensive set of preclinical CAR-T assets originated in China."
Claude
Gemini
Perplexity
ChatGPTPerplexityClaudeChatGPTGeminiOne platform, nine intelligence workflows that map to how BD, CI, R&D, commercial, and biopharma vendor teams actually operate. Every solution shares the same knowledge graph, the same citations, the same agents.
Find and prioritize external innovation opportunities by mechanism, modality, indication, geography, stage, and strategic fit.
Learn more →Track competitor movement across trials, patents, regulatory events, conference disclosures, clinical data, and global pipeline shifts.
Learn more →Map targets, mechanisms, biomarkers, modalities, translational signals, and emerging areas of scientific momentum.
Learn more →Understand future treatment landscapes, unmet need, market evolution, competitive scenarios, and launch-relevant evidence.
Learn more →Surface opportunities early, spot inflection points, quantify white space, and see the setup form before the market prices it in.
Learn more →Help vendors track disease-area narratives, competitor messaging, KOL activity, and account-level signals to sharpen positioning and campaign targeting.
Learn more →Help CROs, CDMOs, tools companies, and service providers identify prospects, buying triggers, account context, and outreach angles.
Learn more →Domain-tuned models, deeply integrated data, and an evidence layer engineered for the way life sciences teams actually make decisions, not adapted from a generic search stack.
Save money. Not every function needs to send a full team to every major meeting. We capture the latest conference data, structure it for you, and make it searchable across BD, CI, R&D, and strategy teams.
"OneZyme.ai has been a highly valuable platform for business development, R&D, and competitive intelligence workflows, particularly in helping synthesize complex biotech and pharma landscapes with a high degree of accuracy and practical relevance. Beyond the strength of the platform itself, the One Zyme team has been exceptionally responsive, thoughtful, and open to feedback, making it clear that they are building with real-world BD, strategy, and executive decision-making needs in mind. I have found the platform to be a strong resource for accelerating insight generation while maintaining the level of rigor required in biotech and pharma."
Traditional life sciences databases were built for search, filtering, and manual analysis. One Zyme was built for the next era: AI-native intelligence workflows that turn fragmented global signals into evidence-linked recommendations, reports, alerts, and action.
Get a strategic briefing tailored to your therapeutic areas, competitors, watchlists, and growth priorities. We'll run a live search against a target of your choice, and walk away with a memo you can take to your CBO.
